MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
3.545
+0.115
+3.35%
After Hours: 3.510 -0.035 -0.99% 16:00 11/22 EST
OPEN
3.350
PREV CLOSE
3.430
HIGH
3.620
LOW
3.350
VOLUME
15.99K
TURNOVER
--
52 WEEK HIGH
9.20
52 WEEK LOW
2.950
MARKET CAP
24.12M
P/E (TTM)
-0.4742
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PYPD last week (1111-1115)?
Weekly Report · 4d ago
PolyPid (PYPD) Gets a Hold from Barclays
TipRanks · 4d ago
Positive Indicators and Financial Stability Support Roy Buchanan’s Optimistic Outlook on PolyPid’s Stock
TipRanks · 11/14 15:55
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress
TipRanks · 11/14 04:05
PolyPid reports 9M results
Seeking Alpha · 11/13 15:52
PolyPid Announces SHIELD II Trial Progress and Financials
TipRanks · 11/13 12:32
PolyPid sees runway into 1Q25
TipRanks · 11/13 12:25
PolyPid Q3 2024 GAAP EPS $(1.22) Misses $(0.96) Estimate; Cash On Hand $9.5M
Benzinga · 11/13 12:07
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.